Tuesday, March 3, 2026

LATEST NEWS

PHARMA

Medtech

Real Estate

Real Estate

Boston Reclaims Top Spot in U.S. Life Sciences Leasing as Market Stabilizes

Life Sciences Times - 0
BOSTON, Mass. — Boston has regained its position as the nation’s leading life sciences market, marking a potential turning point after two years of...

BioMed Realty’s Gateway of Pacific Wins BOMA TOBY Award for Excellence in Life Science Operations

BioMed Realty, Babraham Research Campus Complete Lease-Up of New Laboratory Building

Life Sciences

MassBio Rare Disease Day Forum to Spotlight Research Progress and Patient Challenges

Life Sciences Times - 0
CAMBRIDGE, Mass. — Researchers, patient advocates, biotechnology executives, and state policymakers will gather on Wednesday, February 25, 2026, from 10:00 a.m. to 2:00 p.m....

Trinity Named Top Health Sciences Consulting Firm in 2026 Vault Rankings

Life Sciences Times - 0
WALTHAM, Mass. — Trinity has been ranked among the world’s leading health sciences consulting firms in the 2026 Vault Consulting Rankings, earning recognition in...

Prime Coalition and Rho Impact Expand Free Access to Investor-Grade Climate Impact Data

Life Sciences Times - 0
CAMBRIDGE, Mass. — Prime Coalition and Rho Impact said they have expanded their partnership to provide free access to investor-grade climate impact data, making...

Avangrid Foundation Awards $250,000 in Grants to Wildlife Rehabilitation Centers Nationwide

Life Sciences Times - 0
ORANGE, Conn. — The Avangrid Foundation announced that it has awarded $250,000 in grant funding to 13 wildlife rehabilitation centers across the United States...

Frazier Life Sciences Appoints Charles Fuchs as Senior Advisor

Life Sciences Times - 0
PALO ALTO, Calif. — Frazier Life Sciences, an investment firm focused on innovative therapeutics, has appointed Charles (Charlie) Fuchs, M.D., M.P.H., as Senior Advisor. Dr....

Today's Headlines

Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team

Life Sciences Times - 0
Biotech
BOSTON, Mass. — Syntis Bio has dosed the first patient in its Phase 1/1b SYNTIETY-1 clinical trial evaluating SYNT-101, an investigational once-daily oral therapy...
Advertisment

LATEST ARTICLES

123...805Page 1 of 805

Most Popular

Load more

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv